Aspira Women’s Health (NASDAQ:AWH – Get Free Report) released its earnings results on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.13, Zacks reports.
Aspira Women’s Health Price Performance
AWH traded up $0.01 during mid-day trading on Thursday, hitting $0.11. The stock had a trading volume of 2,284,444 shares, compared to its average volume of 1,153,501. The firm has a market capitalization of $1.94 million, a price-to-earnings ratio of -0.09 and a beta of 1.57. Aspira Women’s Health has a 1-year low of $0.08 and a 1-year high of $3.68. The stock’s fifty day simple moving average is $0.26 and its 200-day simple moving average is $0.61.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on shares of Aspira Women’s Health in a report on Sunday, January 12th. They set a “hold” rating for the company.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Featured Articles
- Five stocks we like better than Aspira Women’s Health
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Top 3 Beverage Stocks Pouring Out Profits
- What is a Special Dividend?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
